Sign in to view content

Randomized, Prospective Study of Aflibercept for Visually Significant Radiation Maculopathy - Interim Analysis

Timothy G. Murray, MD, MBA, FASRS

Video
Published 2016

Related

Ranibizumab for Radiation Retinopathy (RRR) A Prospective, Multicenter Trial of Monthly Versus PRN Dosing for Radiation Retinopathy-Related Macular Edema
Rajiv Anand, MD, FRCS, FASRS
Annual Meeting Talks
2018
Treatment Response to Antioxidant Supplementation Based on CFH and ARMS2Â Genetic Risk Allele Number in AREDS Patients With No AMD at Baseline
Carl C. Awh, MD, FASRS
Annual Meeting Talks
2016
Differences in Surgical Performance in Peeling the ILM for Macular Holes Between Fellows-in-Training and Experienced Vitreoretinal Surgeons
Robert Gizicki, MD, FRCSC, DABO
Annual Meeting Talks
2016

Category: Ocular Oncology

See more